Pay in 4 interest-free payments of $6.65 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
[PMID: 19554482] PubMed record related to this compound for laboratory literature review
Community cycle math using 5 mg vials Cycle length 8 weeks 300 mcg phase 28 days 0.3 mg = 8.4 mg 500 mcg phase 28 days 0.5 mg = 14 mg Total amount 22.4 mg 5 mg vials 5 vials Cycle length 12 weeks 300 mcg phase 28 days 0.3 mg = 8.4 mg 500 mcg phase 56 days 0.5 mg = 28 mg Total amount 36.4 mg 5 mg vials 8 vials Cycle length 16 weeks 300 mcg phase 28 days 0.3 mg = 8.4 mg 500 mcg phase 84 days 0.5 mg = 42 mg Total amount 50.4 mg 5 mg vials 11 vials Vial counts are rounded up to the next full 5 mg vial
NICE recommends monitoring response to treatment through clinical assessment and blood tests as appropriate
Rev1 contributes to proper mitochondrial function via the PARP-NAD(+)-SIRT1-PGC1 axis
The Underlying Cause: It's important to recognize what AHK-Cu is designed to do
